Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of …

…, LH Souter, E Thunnissen… - … of pathology & …, 2018 - meridian.allenpress.com
Context.— In 2013, an evidence-based guideline was published by the College of
American Pathologists, the International Association for the Study of Lung Cancer, and the …

[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …

…, V Roggli, R Rosell, N Saijo, E Thunnissen… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

[HTML][HTML] Reduced lung-cancer mortality with volume CT screening in a randomized trial

…, MA den Bakker, E Thunnissen… - New England journal …, 2020 - Mass Medical Soc
Background There are limited data from randomized trials regarding whether volume-based,
low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among …

Comprehensive genomic profiles of small cell lung cancer

…, OT Brustugun, M Lund-Iversen, E Thunnissen… - Nature, 2015 - nature.com
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …

[HTML][HTML] Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American …

…, JS Saldivar, J Squire, E Thunnissen… - Journal of Thoracic …, 2013 - Elsevier
Objective To establish evidence-based recommendations for the molecular analysis of lung
cancers that are that are required to guide EGFR- and ALK-directed therapies, addressing …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, H Groen, W Timens, H Sietsma, E Thunnissen… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

…, W Timens, H Sietsma, E Thunnissen… - Science translational …, 2010 - science.org
Lung cancer remains one of the leading causes of cancer-related death in developed countries.
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …

[HTML][HTML] Management of lung nodules detected by volume CT scanning

…, C van der Aalst, E Thunnissen… - … England Journal of …, 2009 - Mass Medical Soc
Background The use of multidetector computed tomography (CT) in lung-cancer screening
trials involving subjects with an increased risk of lung cancer has highlighted the problem for …

[HTML][HTML] PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project

…, C Poleri, PA Russell, J Sauter, E Thunnissen… - Journal of Thoracic …, 2018 - Elsevier
Thunnissen reports personal fees from HistoGeneX and Ventana Roche during the conduct
of the study. Dr. Wistuba reports grants and personal fees from Genentech/Roche, Bristol-…

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society …

…, I Petersen, V Roggli, E Thunnissen… - … of Pathology and …, 2013 - meridian.allenpress.com
The new International Association for the Study of Lung Cancer/American Thoracic Society/European
Respiratory Society lung adenocarcinoma classification provides, for the first time, …